1- (1,3- dimethyl- 1- H- pyrazolo(3,4- b)pyridine- 5- carbonyl)- 3- (4- fluoro- 3- (trifluoromethyl)phenyl)urea

Also Known As:

TLK-19705

Networked: 1 relevant articles (0 outcomes, 1 trials/studies)

1.	Atherosclerosis 01/01/2012 - "In conclusion, the results of this study indicate not only considerable therapeutic potential of CCR2 antagonists for diabetic nephropathy and atherosclerosis, but also that TLK-19705 would serve as a powerful tool in mechanistic investigation of these inflammatory diseases." 01/01/2012 - "We examined in this study the effects of TLK-19705 on diabetic nephropathy and atherosclerosis in mouse models. "
2.	Diabetic Nephropathies (Diabetic Nephropathy) 01/01/2012 - "In conclusion, the results of this study indicate not only considerable therapeutic potential of CCR2 antagonists for diabetic nephropathy and atherosclerosis, but also that TLK-19705 would serve as a powerful tool in mechanistic investigation of these inflammatory diseases." 01/01/2012 - "We examined in this study the effects of TLK-19705 on diabetic nephropathy and atherosclerosis in mouse models. "